Related Experiment Videos
Mesangial matrix modulation and glomerulosclerosis
1Department of Pathology, Vanderbilt University Medical Center, Nashville, Tenn., USA. agnes.fogo@mcmail.vanderbilt.edu
Abstract:
Progressive deterioration of the kidney is common to many renal diseases. The structural injuries which lead to this progressive loss of function consist of focal segmental glomerulosclerosis and tubulointerstitial fibrosis and atrophy. These processes were previously thought to be inexorable, regardless of the primary disease. However, recent observations point to the possibility of reversal of sclerosis. Mesangial matrix accumulation is the cornerstone of glomerulosclerosis and results when matrix synthesis exceeds matrix degradation. The renin-angiotensin system appears to be one central component of this process, with links to numerous mechanisms which promote matrix accumulation. Most recently, direct induction of plasminogen activator inhibitor-1 by angiotensin has been recognized. Plasminogen activator inhibitor-1 not only promotes thrombosis, but also inhibits matrix degradation. The various mechanisms which modulate mesangial matrix accumulation and their potential reversibility are reviewed.
Insights
Kidney disease progression, marked by glomerulosclerosis and fibrosis, may be reversible. The renin-angiotensin system drives matrix accumulation, but understanding these mechanisms offers hope for reversing kidney damage.
Area of Science:
- Nephrology
- Renal Pathology
- Molecular Biology
Background:
- Progressive kidney disease leads to irreversible structural injuries like glomerulosclerosis and tubulointerstitial fibrosis.
- These fibrotic processes were traditionally considered unavoidable, irrespective of the underlying renal disease.
- Emerging evidence suggests that sclerosis in the kidneys might be a reversible condition.
Purpose of the Study:
- To review the mechanisms of mesangial matrix accumulation in glomerulosclerosis.
- To explore the role of the renin-angiotensin system in promoting matrix accumulation.
- To discuss the potential reversibility of renal fibrotic processes.
Main Methods:
- Review of existing literature on renal disease progression and matrix accumulation.
- Analysis of the renin-angiotensin system's involvement in mesangial matrix synthesis and degradation.
- Examination of plasminogen activator inhibitor-1's role in thrombosis and matrix degradation.
Main Results:
- Mesangial matrix accumulation, central to glomerulosclerosis, occurs when synthesis outpaces degradation.
- The renin-angiotensin system is a key regulator, influencing multiple pathways that enhance matrix deposition.
- Angiotensin directly induces plasminogen activator inhibitor-1, which inhibits matrix degradation and promotes thrombosis.
Conclusions:
- The progression of renal diseases involves structural injuries that may not be immutable.
- The renin-angiotensin system plays a critical role in driving mesangial matrix accumulation.
- Understanding these pathways, including plasminogen activator inhibitor-1, offers potential therapeutic targets for reversing kidney damage.